|
|
Bio
Biotech investor |
||||||||
|
|
Matt
via Twitter |
Nov 20 9:25 AM |
|
@jman001 $BCRX Management of most companies care little about speculators (option players). They care about long-term investors.
Comment |
||
|
|
Matt
via Twitter |
Nov 20 7:49 AM |
|
Well, it looks like Peramivir got emergency authorization in Korea... $BCRX
Comment |
||
|
|
Matt
via Twitter |
Nov 20 7:46 AM |
|
$NVAX does public offering as well, wow, all the H1N1 stocks raising cash here...
Comment |
||
|
|
Matt
via Twitter |
Nov 19 1:47 PM |
|
@TiltTrader That's probably Morgan Stanley finally supporting the bid for the offering. $BCRX
Comment |
||
|
|
Matt
via Twitter |
Nov 19 10:44 AM |
|
Buying more $BCRX because well, I buy when there is fear, and there are a lot of people afraid right now, including longs.
Comment |
||
|
|
Matt
via Twitter |
Nov 18 2:09 PM |
|
@Googleo When you're sharing information based on fact, it's hardly pumping. This was completely unexpected. $BCRX
Comment |
||
|
|
Matt
via Twitter |
Nov 17 8:23 PM |
|
My thoughts on the $BCRX offering today. http://bit.ly/1OPLzi
Comment |
||
|
|
Matt
via Twitter |
Nov 14 6:53 PM |
|
RT @johnwelshphd: @mavrickteam No, $NVAX has never been about the swine flu, said that all along. It's about future, and it's technology.
Comment |
||
|
|
Matt
via Twitter |
Nov 12 9:17 PM |
|
$BCRX - Korea's Green Cross Seeks To Unveil Injectable Flu Antiviral Peramivir Even Before KFDA Approval - http://bit.ly/3SEW1D
Comment |
||
|
|
Matt
via Twitter |
Nov 12 2:43 PM |
|
CNN is playing the peramivir story throughout the day. Great PR for a life-saving drug. $BCRX
Comment |
||
|
|
Matt
via Twitter |
Nov 12 2:06 PM |
|
@mhughey64 By "just came out" you mean yesterday. :) $BCRX
Comment |
||
|
|
Matt
via Twitter |
Nov 12 1:50 PM |
|
#H1N1 $BCRX CDC new estimates 22M ppl have bcome ill so far; 98,000 hospitalized; 63k - 153k hospitalizations range; 3,900 ppl dead in US
Comment |
||
|
|
Matt
via Twitter |
Nov 12 1:30 PM |
|
@optionsizzle Saw that as well, thanks. $BCRX
Comment |
||
|
|
Matt
via Twitter |
Nov 12 1:03 PM |
|
RT @harryboxer: $BCRX daily chart shows it cming up to test key overhead resistance from the Aug highs. Could get it quickly into 17+ area.
Comment |
||
|
|
Matt
via Twitter |
Nov 12 12:06 PM |
|
Although I won't short a biotech or company trying to save lives, I do think $HEB is on the avoid list. @johnwelshphd agrees with me here.
Comment |
||
|
|
Matt
via Twitter |
Nov 12 12:04 PM |
|
$BCRX and $SVA are the two flu stock winners this season. $NVAX will mature in a year or two.
Comment |
||
|
|
Matt
via Twitter |
Nov 12 11:59 AM |
|
$BCRX Picked up another 9,500 shares on dip this morning at 11.73-.11.75. Total position: 64,500k stock/deep in the money options
Comment |
||
|
|
Matt
via Twitter |
Nov 12 11:45 AM |
|
RT @newworldinvestr: Peramivir from $BCRX cures swine flu in the ICU! Get the word out to ICU doctors to call the CDC! Retweet this now!
Comment |
||